Product Datasheet
Daxx Antibody
Catalog Number: 48986
Technical:tech@swbio.com
Information:info@swbio.com
Description
- Swiss-Prot No.:
- Swiss-Prot#:Q9UER7
- Form of Antibody:
- 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
- Immunogen:
- recombinant protein
- appl_detail:
- WB: 1:1,000-1:2,000
ICC: 1:50-1:200
FC: 1:50-1:100
- other_names:
- BING 2 antibody BING2 antibody CENP-C binding protein antibody DAP 6 antibody DAP6 antibody DAXX antibody DAXX_HUMAN antibody Death associated protein 6 antibody Death domain associated protein 6 antibody Death
- Purification:
- ProA affinity purified
- Applications:
- WB, ICC, FC
- Background:
- Activation of the cell surface receptor FAS by FAS ligand leads to the initiation of apoptosis, a process necessary for the regulation of the immune system and tissue homeostasis. FAS-mediated apoptosis appears to involve a number of divergent and overlapping pathways. Daxx appears to be a central component of a FAS-mediated apoptotic pathway involving the activation of Jun N-terminal kinase (JNK). Although Daxx itself does not contain a death domain, it specifically binds to the death domain of FAS. Overexpression of Daxx activates the JNK pathway and enhances FAS-mediated apoptosis. The Daxx apoptotic pathway acts cooperatively with but is distinct from the FAS-mediated pathway that involves interactions between the death domain-containing protein FADD and the cysteine protease FLICE. Unlike the FAS-FADD-FLICE pathway, the Daxx pathway is sensitive to the apoptotic inhibitor protein Bcl-2.
© Signalway Biotechnology All Rights Reserved.